Kishan Bellamkonda
Lund, M, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer.
Journal: Anticancer research
Published: February 10, 2019
Disrupting Inflammation-Associated CXCL8-CXCR1 Signaling Inhibits Tumorigenicity Initiated by Sporadic- and Colitis-Colon Cancer Stem Cells.
Journal: Neoplasia (New York, N.Y.)
Published: November 02, 2018
Montelukast, a CysLT1 receptor antagonist, reduces colon cancer stemness and tumor burden in a mouse xenograft model of human colon cancer.
Journal: Cancer letters
Published: July 04, 2018
The eicosanoids leukotriene D4 and prostaglandin E2 promote the tumorigenicity of colon cancer-initiating cells in a xenograft mouse model.
Journal: BMC cancer
Published: January 04, 2016
Cysteinyl leukotriene 1 receptor influences intestinal polyp incidence in a gender-specific manner in the ApcMin/+ mouse model.
Journal: Carcinogenesis
Published: October 20, 2014
The impact of inflammatory lipid mediators on colon cancer-initiating cells.
Journal: Molecular carcinogenesis
Published: November 27, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026